Consistent with previous studies, we identified PAK1 and PAK2 as selective and cancer‐specific vulnerabilities, underscoring their potential as key drivers of tumorigenesis and cancer progression (Lei et al., 2022; Somanath et al., 2023). This evidence concerns the gene PAK1 and cancer.